OurCrowd launched a new webinar series called ‘Teach-In Tuesdays’. In this series, we’ll explore investing in early-stage Israeli companies, identify and explain influential tech trends, stay up-to-date with the crowdfunding industry, and examine actionable insights from our own experience running OurCrowd’s investment platform.
Yesterday, we held a webinar as part of the OurCrowd Teach-In Tuesdays series on the opportunities and challenges of reimbursement in the MedTech industry. When we invest in a medtech startup, investors frequently ask about the probability of getting a device approved and reimbursed for in the US. This webinar was intended for investors to learn about the regulatory and payment environment for medtech companies selling into the U.S.
Additional topics covered in the webinar:
- Reimbursement basics: what is coding, coverage and payment?
- Differences by setting of care: devices to be used inpatient vs devices to be used outpatient
- Trends in collection of evidence and health economic data
- ACA (Obamacare) trends relevant for medical device manufacturers
Fauzea Hussain, Vice President of Avalere Health. Ms. Hussain advises clients on integrated market access strategies, product commercialization tactical plans, and public and private payer engagement activities.
To stay updated on future events and the best news from the Startup Nation, sign up for our newsletter, email us, and follow us on social media.
To contact Fauzea Hussain, email FHussain@AvalereHealth.net
To contact Debbie Garner of the Avalare Health Israel office, email firstname.lastname@example.org
View the FULL program
Download/view the presentation